micro-community-banner
 
  • Saved

November 18, 2024
Brain abscesses caused by Listeria monocytogenes in a patient with myasthenia gravis - Case report and systematic review - PubMed

Brain abscesses caused by Listeria monocytogenes in a patient with myasthenia gravis - Case report and systematic review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38075415/

This case highlights the importance of L. monocytogenes as a cause of brain abscesses in populations at risk, including myasthenic patients. The challenge of diagnosing and treating this condition is...

Invasive listeriosis in myasthenic patients on immunosuppressive therapy can cause fatal brain abscesses, with high mortality and complex treatment challenges due to limited diagnostic yield and sparse literature.

  • Saved

November 11, 2024
Brain abscesses caused by Listeria monocytogenes in a patient with myasthenia gravis - Case report and systematic review - PubMed

Brain abscesses caused by Listeria monocytogenes in a patient with myasthenia gravis - Case report and systematic review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38075415/

This case highlights the importance of L. monocytogenes as a cause of brain abscesses in populations at risk, including myasthenic patients. The challenge of diagnosing and treating this condition is...

A 75-year-old with myasthenia gravis developed fatal listeriosis with brain abscesses. Systematic review shows high mortality and challenges in diagnosis and treatment, highlighting risks in immunocompromised patients.

  • Saved

November 11, 2024
Erythroderma combined with deeper dermal dermatophytosis due to Trichophyton rubrum in a patient with myasthenia gravis: first case report and literature review - PubMed

Erythroderma combined with deeper dermal dermatophytosis due to Trichophyton rubrum in a patient with myasthenia gravis: first case report and literature review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37957543/

This case report shows that immunosuppressed patients with long histories of superficial mycoses tend to have a higher risk of developing invasive dermatophytic infections or disseminated fungal infections. Dermatologists should...

A rare case of erythroderma and deeper dermal dermatophytosis due to Trichophyton rubrum in a myasthenia gravis patient highlights the risk of invasive fungal infections in immunosuppressed individuals.

  • Saved

November 08, 2024
Emerging Myositis Treatments and Targeted Therapies – Insights from IgNS 2024

In this IgNS 2024 conference video, Dr. Eleni Tiniakou, a rheumatologist and assistant professor at Johns Hopkins, shares advancements in myositis treatment approaches. She highlights evidence-based therapies, including interferon pathway inhibitors, B-cell targeting, and early research on CAR T-cell applications. Dr. Tiniakou emphasizes the importance of personalized approaches to address the diverse pathogenic factors in myositis treatment. These insights provide physicians tools to better tailor treatments across myositis subtypes and improve patient outcomes.

  • Saved

November 07, 2024
Emerging Myositis Treatments and Targeted Therapies – Insights from IgNS 2024

In this IgNS 2024 conference video, Dr. Eleni Tiniakou, a rheumatologist and assistant professor at Johns Hopkins, shares advancements in myositis treatment approaches. She highlights evidence-based therapies, including interferon pathway inhibitors, B-cell targeting, and early research on CAR T-cell applications. Dr. Tiniakou emphasizes the importance of personalized approaches to address the diverse pathogenic factors in myositis treatment. These insights provide physicians tools to better tailor treatments across myositis subtypes and improve patient outcomes.